BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 15272226)

  • 21. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.
    Katsuta M; Miyashita M; Makino H; Nomura T; Shinji S; Yamashita K; Tajiri T; Kudo M; Ishiwata T; Naito Z
    Exp Mol Pathol; 2005 Apr; 78(2):123-30. PubMed ID: 15713437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and localization of hypoxia inducible factor-1alpha mRNA in the porcine ovary.
    Boonyaprakob U; Gadsby JE; Hedgpeth V; Routh PA; Almond GW
    Can J Vet Res; 2005 Jul; 69(3):215-22. PubMed ID: 16187552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypoxia-inducible factor-1 alpha dependent expression and significance of the related multidrug resistance genes induced by hypoxia in human hepatocarcinoma cell].
    Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Wang HP
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):277-81. PubMed ID: 15842930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
    Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
    Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha.
    An WG; Kanekal M; Simon MC; Maltepe E; Blagosklonny MV; Neckers LM
    Nature; 1998 Mar; 392(6674):405-8. PubMed ID: 9537326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
    Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Regulation of hypoxia-inducible factor-1alpha expression].
    Du KM; Chen GQ; Chen Z
    Ai Zheng; 2004 Sep; 23(9):1098-102. PubMed ID: 15363211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
    Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
    Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc.
    Mazure NM; Chauvet C; Bois-Joyeux B; Bernard MA; Nacer-Chérif H; Danan JL
    Cancer Res; 2002 Feb; 62(4):1158-65. PubMed ID: 11861398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
    Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
    Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
    Cohen NA; Lai SY; Ziober AF; Ziober BL
    Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
    Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
    Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].
    Tang XD; Zhou X; Zhang QZ; Le AD; Zhou KY
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2872-7. PubMed ID: 19080502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol reduces the hypoxia-induced resistance to doxorubicin in breast cancer cells.
    Mitani T; Ito Y; Harada N; Nakano Y; Inui H; Ashida H; Yamaji R
    J Nutr Sci Vitaminol (Tokyo); 2014; 60(2):122-8. PubMed ID: 24975222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Resveratrol increases sensitivity of CNE2 cells to chemotherapeutic drugs under hypoxia].
    Quan F; Zhang SQ; Bai YX; Yao XB; Li HH; Yu L; Pan CE
    Zhong Xi Yi Jie He Xue Bao; 2009 Oct; 7(10):952-7. PubMed ID: 19828106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells.
    Wen Y; Zhao RQ; Zhang YK; Gupta P; Fu LX; Tang AZ; Liu BM; Chen ZS; Yang DH; Liang G
    Oncotarget; 2017 May; 8(18):29760-29770. PubMed ID: 28423656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of hypoxia-inducible factor-1alpha silencing on the sensitivity of human brain glioma cells to doxorubicin and etoposide.
    Chen L; Feng P; Li S; Long D; Cheng J; Lu Y; Zhou D
    Neurochem Res; 2009 May; 34(5):984-90. PubMed ID: 18937067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selected Contribution: Osteocytes upregulate HIF-1alpha in response to acute disuse and oxygen deprivation.
    Gross TS; Akeno N; Clemens TL; Komarova S; Srinivasan S; Weimer DA; Mayorov S
    J Appl Physiol (1985); 2001 Jun; 90(6):2514-9. PubMed ID: 11356821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances.
    Surh Y
    Mutat Res; 1999 Jul; 428(1-2):305-27. PubMed ID: 10518003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity.
    Sullivan R; Paré GC; Frederiksen LJ; Semenza GL; Graham CH
    Mol Cancer Ther; 2008 Jul; 7(7):1961-73. PubMed ID: 18645006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.